- 1. 2 lysophosphatidylcholine acylhydrolase
- [An enzyme that catalyzes the hydrolysis of a single fatty acid ester bond in lysoglycerophosphatidates with the formation of glyceryl phosphatidates and a fatty acid. EC 3.1.1.5. ( MSH )] (UMLS (CSP) C0024361) =Amino Acid, Peptide, or Protein; Enzyme ;
=carboxylesterase;
| - 51. Lymph Node Stage N0
- [No evidence of regional lymph node metastasis, in accordance with TNM classification system guidelines. (from AJCC 6th Ed.) ( NCI )] (UMLS (NCI) C0441959) =Finding
|
- 2. Ly 127935
- (UMLS (NCI) C0878140) =Organic Chemical; Antibiotic
| - 52. Lymph Node Stage N1
- (UMLS (NCI) C0441962) =Finding
|
- 3. LY 139481
- (UMLS (NCI) C0752233) =Organic Chemical; Pharmacologic Substance ;
| - 53. Lymph Node Stage N1a
- (UMLS (NCI) C0456906) =Finding
|
- 4. LY 170053
- (UMLS (NCI) C0171021) =Organic Chemical; Pharmacologic Substance ;
| - 54. Lymph Node Stage N1b
- (UMLS (NCI) C0456908) =Finding
|
- 5. LY 295501
- (UMLS (NCI) C0299219) =Organic Chemical; Pharmacologic Substance ;
| - 55. Lymph Node Stage N2
- (UMLS (NCI) C0441960) =Finding
|
- 6. LY 355703
- (UMLS (NCI) C0756542) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 56. Lymph Node Stage N2a
- (UMLS (NCI) C0445079) =Finding ;
|
- 7. Ly-133314
- (UMLS (NCI) C0126317) =Organic Chemical; Pharmacologic Substance ;
| - 57. Lymph Node Stage N2b
- (UMLS (NCI) C0445080) =Finding ;
|
- 8. LY-156758
- (UMLS (NCI) C0284562) =Organic Chemical; Pharmacologic Substance ;
| - 58. Lymph Node Stage N2c
- (UMLS (NCI) C0445081) =Finding ;
|
- 9. Ly1 antigen
- [ ] (UMLS (CSP) C0599714) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 59. Lymph Node Stage N3
- (UMLS (NCI) C0441961) =Finding
|
- 10. LY127809
- (UMLS (NCI) C0701027) =Organic Chemical; Pharmacologic Substance ;
| - 60. Lymph Node Stage NX
- [Status of regional lymph nodes cannot be assessed in accordance with TNM classification system guidelines. (from AJCC 6th Ed.) ( NCI )] (UMLS (NCI) C0445085) =Finding ;
|
- 11. LY146032
- (UMLS (NCI) C0918009) =Amino Acid, Peptide, or Protein; Antibiotic ;
| - 61. Lymph Node Stage pN0
- [No morphologic evidence of regional lymph node metastasis by routine histologic staining, in accordance with TNM classification system guidelines. ( NCI )] (UMLS (NCI) C0332396) =Finding
|
- 12. LY186641
- (UMLS (NCI) C0950735) =Organic Chemical; Pharmacologic Substance
| - 62. Lymph Node Stage pN1
- (UMLS (NCI) C0332397) =Finding
|
- 13. LY188011
- [ ] (UMLS (CSP) C0701235) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 63. Lymph Node Stage pN2
- (UMLS (NCI) C0332398) =Finding
|
- 14. LY231514
- (UMLS (NCI) C0251353) =Organic Chemical; Pharmacologic Substance ;
| - 64. Lymph Node Stage pN3
- (UMLS (NCI) C0332399) =Finding
|
- 15. LY293111
- [A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called leukotriene B4 receptor antagonists. ( NCI )] (UMLS (NCI) C0298619) =Organic Chemical; Pharmacologic Substance
| - 65. Lymph Node Tissue
- [Tissue composed of specialized cells that are organized as a definite organ, situated along the course of lymphatic vessels, and consisting of an outer cortical and an inner medullary part. The lymph nodes are the main source of lymphocytes of the peripheral blood and serve as a defense mechanism by removing noxious agents, such as bacteria and toxins, and probably play a role in antibody production. ( NCI )] (UMLS (NCI) C0440747) =Tissue ;
|
- 16. LY303366
- (UMLS (NCI) C0532508) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 66. Lymph Node Trabecula
- [The supporting and anchoring strand of connective tissue radiating out from the capsule through the interior of the lymph node. ( NCI )] (UMLS (NCI) C1184179) Lymph Node Trabeculae =Body Part, Organ, or Organ Component
|
- 17. LY335348
- (UMLS (NCI) C0917978) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 67. Lymph Node Tuberculosis
- [Infection of the lymph nodes by tuberculosis. Tuberculous infection of the cervical lymph nodes is scrofula. ( MSH )] (UMLS (NCI) C0041316) =Disease or Syndrome ;
=Adenitis;
tuberculosis =King's Evil |
- 18. LY335979
- (UMLS (NCI) C0380527) =Organic Chemical; Pharmacologic Substance ;
| - 68. LYMPH STRUCTURE OP NEC
- [ ] (UMLS (ICD9CM) C0842101) Other operations on lymphatic structures =Diagnostic Procedure
|
- 19. LY353381
- (UMLS (NCI) C0677791) =Organic Chemical; Pharmacologic Substance ;
| - 69. Lymph Vessel Neoplasm
- [A benign or malignant neoplasm arising from the lymphatic vessels. ( NCI )] (UMLS (NCI) C0206619) =Neoplastic Process ;
=Neoplasms by Histologic Type;
=lymphangioma;
Lymphangioleiomyoma;
Lymphangioendothelial Sarcoma |
- 20. LY353381 hydrochloride
- [A hormone substance used in the treatment of some types of cancer. ( NCI )] (UMLS (NCI) C0950979) LY353381.HCl =Organic Chemical; Pharmacologic Substance
| - 70. LYMPH/HEMATPOITC TIS NEC
- [ ] (UMLS (ICD9CM) C1706492) Other lymphatic and hematopoietic tissues =Neoplastic Process
|
- 21. LY6E
- [LY6E gene encodes a cell surface protein containing 20 N-terminal amino acids corresponding to a signal peptide and an extracellular sequence of 111 amino acids. LY6E protein shares some homology with CD59 and some growth factor receptors; highest homology is with the murine LY6 multigene family of small cysteine-rich proteins differentially expressed in several hematopoietic cell lines and with apparent signal transduction function. RIGE is the closest human LY6 family homolog. RIGE expression is not restricted to myeloid differentiation; it is also present in thymocytes and other tissues at different levels. By Northern blot analysis, the highest expression of RIGE was found in liver, kidney, and ovary in addition to peripheral blood leukocytes. (OMIM) ( NCI )] (UMLS (NCI) C1099221) Lymphocyte Antigen 6 Complex, Locus E;
Retinoic Acid-Induced Gene E Protein;
Stem Cell Antigen 2;
Thymic Shared Antigen-1;
=Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 71. LYMPHADENITIS NOS
- (UMLS (ICD9CM) C0024207) =Disease or Syndrome ;
|
- 22. LY6E
- [This gene plays a role in signal transduction. ( NCI )] (UMLS (NCI) C1334353) LY6E Gene;
Lymphocyte Antigen 6 Complex, Locus E Gene =Gene or Genome ;
| - 72. Lymphadenopathic Kaposi Sarcoma
- [A Kaposi sarcoma affecting the lymph nodes. ( NCI )] (UMLS (NCI) C1334457) Lymphadenopathic Kaposi's Sarcoma =Neoplastic Process
|
- 23. LY900003
- (UMLS (NCI) C1135123) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 73. Lymphadenopathy with Polyclonal Hypergammaglobulinemia
- (UMLS (NCI) C1334458) =Finding
|
- 24. lyase
- [cleave C-C, C-O, C-N, and other bonds by other means than by hydrolysis or oxidation. ( CSP )] (UMLS (CSP) C0024188) =Amino Acid, Peptide, or Protein; Enzyme =enzyme;
=ferrochelatase;
carbon sulfur lyase;
carbon carbon lyase;
carbon oxygen lyase;
carbon nitrogen lyase;
phosphorus oxygen lyase;
carbon oxygen lyase;
| - 74. Lymphangioendothelial Sarcoma
- [A malignant neoplasm arising from the endothelial cells of the lymphatic vessels. ( NCI )] (UMLS (NCI) C0024224) =Neoplastic Process ;
=Lymph Vessel Neoplasm;
Connective Tissue Sarcoma |
- 25. Lyase Gene
- [Lyase Genes encode Lyases, a class of enzymes that catalyze the hydration-dehydration cleavage of C-C, C-O, C-N, and other bonds by means other than hydrolysis or oxidation. (NCI) ( NCI )] (UMLS (NCI) C1334456) =Gene or Genome
| - 75. Lymphangiogram
- (UMLS (HL7) C1548879) =Health Care Activity =Consent Type;
|
- 26. Lyc-O-Mato
- (UMLS (NCI) C0965256) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance
| - 76. Lymphangiogram
- [An x-ray study of lymph nodes and lymphatic vessels made visible by the injection of a special dye. ( NCI )] (UMLS (NCI) C0024219) =Diagnostic Procedure ;
|
- 27. Lycopene
- [A red pigment found in tomatoes and some fruits. ( NCI )] (UMLS (NCI) C0065331) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance
| - 77. Lymphangiogram of upper limb
- [ ] (UMLS (ICD9CM) C0202999) =Diagnostic Procedure
|
- 28. Lycopene/Multivitamins
- (UMLS (NCI) C1134707) =Therapeutic or Preventive Procedure ;
| - 78. Lymphangioleiomyoma
- [A neoplasm with perivascular epithelioid cell differentiation, often associated with tuberous sclerosis. It is characterized by the presence of smooth muscle and epithelioid cells, and the proliferation of lymphatic vessels. Sites of involvement include the lymph nodes, lung, mediastinum, and retroperitoneum. ( NCI )] (UMLS (NCI) C0024223) =Neoplastic Process ;
=Lymphoproliferative Disorder;
Lymph Vessel Neoplasm =LAM;
|
- 29. Lycopersicon esculentum
- [A plant species of the family SOLANACEAE, native of South America, widely cultivated for their edible, fleshy, usually red fruit. ( MSH )] (UMLS (CSP) C1140676) =Plant
| - 79. Lymphangioleiomyomatosis of Skin
- [Lymphangiomyomatosis involving the dermis. ( NCI )] (UMLS (NCI) C0340116) =Neoplastic Process
|
- 30. lycopodine alkaloid
- [ ] (UMLS (CSP) C0596867) =Organic Chemical ;
| - 80. lymphangioma
- [A benign neoplasm arising from the lymphatics. The tumor is composed of dilated lymphatic channels. Painless swelling is the usual clinical manifestation. ( NCI )] (UMLS (CSP) C0024221) =Neoplastic Process ;
=Lymph Vessel Neoplasm;
=Cystic Hygroma;
|
- 31. lycopodium alkaloid
- [ ] (UMLS (CSP) C0598791) =Organic Chemical ;
| - 81. Lymphangioma Circumscriptum
- [A localized lymphangioma characterized by microcystic changes. ( NCI )] (UMLS (NCI) C0343089) =Neoplastic Process
|
- 32. lycorine
- [ ] (UMLS (CSP) C0065335) =Organic Chemical; Biologically Active Substance ;
| - 82. Lymphangioma of Parotid
- [A lymphangioma arising from the parotid gland. ( NCI )] (UMLS (NCI) C1335361) Lymphangioma of Parotid Gland;
Lymphangioma of the Parotid;
Lymphangioma of the Parotid Gland;
Parotid Gland Lymphangioma;
Parotid Lymphangioma =Neoplastic Process ;
|
- 33. lying
- [ ] (UMLS (CSP) C0600261) =Individual Behavior
| - 83. Lymphangiomatosis
- [A lymphangioma affecting several anatomic sites. ( NCI )] (UMLS (NCI) C0334102) =Disease or Syndrome
|
- 34. LYL1
- [This gene plays a role in transcriptional regulation and is involved in the pathogenesis of acute lymphoblastic leukemia. ( NCI )] (UMLS (NCI) C1334354) LYL1 Gene;
Lymphoblastic Leukemia Derived Sequence 1 Gene =Gene or Genome ;
◊ [Lymphoblastic Leukemia Derived Sequence 1, encoded by the human LYL1 gene, contains 1 basic helix-loop-helix (bHLH) domain. Efficient DNA binding of this protein requires dimerization with another bHLH protein. This gene is involved in a form of T-cell acute lymphoblastic leukemia (T-ALL) through a chromosomal translocation t(7;9)(q35;p13) which involves LYL1 and T-cell receptor beta chain (TCRB) genes. (from Swiss-Prot) ( NCI )] (UMLS (NCI) C1334355) Lyl-1 Protein; Lymphoblastic Leukemia Derived Sequence 1 Amino Acid, Peptide, or Protein; Biologically Active Substance | - 84. Lymphangiosarcoma of Skin
- [A malignant vascular neoplasm arising from the lymphatic vessels. ( NCI )] (UMLS (NCI) C0346082) =Neoplastic Process
|
- 35. LYM
- [The determination of the number of lymphocytes in a blood sample. ( NCI )] (UMLS (NCI) C0200635) =Laboratory Procedure
| - 85. Lymphangitic Carcinomatosis
- [Extensive infiltration of the lymphatic vessels by cancer cells, resulting in widespread cancer dissemination. The lymphatic vessels appear as palpable, cord-like structures, especially in skin areas overlying the carcinoma.--2004 ( NCI )] (UMLS (NCI) C0238258) =Neoplastic Process
|
- 36. Lyme arthritis
- [WHAT: Lyme arthritis. ( AIR )] (UMLS (CSP) C0242381) =Disease or Syndrome ;
| - 86. LYMPHANGITIS
- (UMLS (ICD9CM) C0024225) =Disease or Syndrome ;
=adenopathy;
|
- 37. Lyme borreliosis
- [recurrent multisystemic infectious disease caused by a spirochete, Borrelia burgdorferi, which is transmitted chiefly by Ixodes ticks; it is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. ( CSP )] (UMLS (CSP) C0024198) =Disease or Syndrome ;
=Borrelia Infections;
Tick-Borne Diseases =Erythema Chronicum Migrans;
Lyme Neuroborreliosis | - 87. lymphatic cancer
- [ ] (UMLS (CSP) C0920571) =Neoplastic Process
|
- 38. Lyme disease
- [Lyme disease vaccine ( HL7V3.0 )] (UMLS (HL7) C0717360) LYME DISEASE VACCINE;
LYME DISEASE VACCINE PREPARATION;
=Organic Chemical; Pharmacologic Substance; Immunologic Factor =[IM100] VACCINES;
Unclassified Ingredients;
Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 88. Lymphatic Capillary
- (UMLS (NCI) C0162405) =Body Part, Organ, or Organ Component ;
|
- 39. Lympedema clinic
- (UMLS (HL7) C1552783) =Intellectual Product =Outpatient facility;
| - 89. lymphatic circulation
- [lymphatic vessels and the movement of lymph within these vessels, as well as the circuitous movement of interstitial fluid from body tissues to the circulatory system. ( CSP )] (UMLS (CSP) C0596870) =Organ or Tissue Function ;
=lymphatic system;
|
- 40. lymph
- [transparent slightly yellow fluid found in the lymphatic vessels; contains lymphocytes; it is derived from the tissue fluids, collected from all parts of the body and returned to the blood via the lymphatic system. ( CSP )] (UMLS (NCI) C0024202) =Body Substance ;
=body fluid;
lymphatic tissue | - 90. LYMPHATIC DIAG PROC NEC
- [ ] (UMLS (ICD9CM) C0176698) =Diagnostic Procedure
|
- 41. lymph flow
- [ ] (UMLS (CSP) C0596868) =Organ or Tissue Function ;
| - 91. lymphatic duct
- [ ] (UMLS (CSP) C0447201) =Body Part, Organ, or Organ Component
|
- 42. lymph gland
- [any of the accumulations of lymphoid tissue organized as definite lymphoid organs, varying from 1 to 25 mm in diameter situated along the course of lymphatic vessels and consisting of an outer cortical and an inner medullary part; the main source of lymphocytes of the peripheral blood and, as part of the reticuloendothelial system, serves as a defense mechanism by removing noxious agents, such as bacteria and toxins. ( CSP )] (UMLS (NCI) C0024204) =Body Part, Organ, or Organ Component ;
=lymphatic tissue;
Body Part =HEV;
| - 92. lymphatic duct drainage
- [ ] (UMLS (CSP) C0598792) =Organ or Tissue Function ;
|
- 43. Lymph Node Cancer
- [A primary or metastatic malignant tumor involving the lymph node. Lymphomas and metastatic carcinomas are representative examples. — 2004 ( NCI )] (UMLS (NCI) C0948627) Malignant Lymph Node Neoplasm =Neoplastic Process
| - 93. lymphatic neoplasm
- [ ] (UMLS (CSP) C0948214) =Neoplastic Process
|
- 44. Lymph Node Capsule
- (UMLS (NCI) C0229699) =Body Part, Organ, or Organ Component
| - 94. Lymphatic Spread
- (UMLS (NCI) C1334459) =Finding
|
- 45. Lymph Node Cortex
- [The portion of the lymph node that contains nodules with germinal centers where B lymphocyte mature into plasma cells after activation. The nodules are separated by diffuse lymphatic tissue, lymph sinuses and trabeculae. ( NCI )] (UMLS (NCI) C0933402) =Body Part, Organ, or Organ Component
| - 95. lymphatic system
- [system of organs and tissues that process and transport immune cells and lymph. ( CSP )] (UMLS (NCI) C0024235) =Body System ;
=allergic/immunologic body system;
=lymphatic tissue;
lymphatic circulation |
- 46. Lymph Node Disorder
- (UMLS (NCI) C0272394) =Disease or Syndrome
| - 96. LYMPHATIC SYSTEM SCAN
- [ ] (UMLS (ICD9CM) C0412375) =Diagnostic Procedure
|
- 47. Lymph Node Hilum
- (UMLS (NCI) C0229703) =Body Part, Organ, or Organ Component
| - 97. lymphatic tissue
- [specialized tissues that are components of the lymphatic system, providing fixed locations within the body where a variety of lymphocytes can form, mature, and multiply. ( CSP )] (UMLS (CSP) C0024296) =Tissue ;
=lymphatic system;
=bursa of Fabricius;
lymph;
lymph gland;
reticuloendothelial system;
Reticuloendothelial System, Spleen;
Reticuloendothelial System, Thymus;
secretory immune system;
|
- 48. Lymph Node Involvement
- (UMLS (NCI) C0806692) =Finding ;
| - 98. lymphatic tissue surgery
- [heading term for surgery involving lymphatic tissues and organs. ( CSP )] (UMLS (CSP) C1533607) =Therapeutic or Preventive Procedure; ;
=Operation;
=adenoidectomy;
excision of the lymph node;
splenectomy;
thymectomy;
lymphatic tissue transplantation;
|
- 49. Lymph Node Mass
- (UMLS (NCI) C0746921) Nodal Mass;
=Disease or Syndrome | - 99. lymphatic tissue transplantation
- [transference of a lymphatic tissue within an individual, between individuals of the same species, or between individuals of different species. ( CSP )] (UMLS (CSP) C0596872) =Therapeutic or Preventive Procedure ;
=transplantation;
lymphatic tissue surgery =THYMUS TRANSPLANTATION |
- 50. lymph node neoplasm
- [new abnormal lymph node tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0596869) =Neoplastic Process ;
=lymphoma;
| - 100. Lymphatic Vessel
- [Subdivision of the lymphatic tree (organ) that is elongated and tubular, the lumen of which is continuous with the lumen of veins, directly or indirectly; it conveys lymph from organs and body parts to lymph nodes and veins; together with other lymphatic vessels and lymph nodes, it constitutes the lymphatic tree (organ). Examples: bronchomediastinal lymph duct, thoracic duct. ( UWDA )] (UMLS (NCI) C0229889) =Body Part, Organ, or Organ Component
|
home
